Moreover, the increased expression of angiotensin-converting enzyme 2 (ACE-2) in lungs, brain, heart, kidney, and veins in patients taking SGLT-2i [20, 21], which, as a receptor for SARS-CoV-2, could, in theory, lead to higher risk of infection [22], represent further counterarguments. This evidence concerns the gene ACE2 and infection.